Quantification of Artemisinin in Artemisia annua and Derived Products

Comprehensive Analytical Quantification of Artemisinin in Artemisia annua and Derived Products – A Specialised Testing Service for Quality Assurance, Process Optimisation, and Regulatory Compliance

Artemisinin, a sesquiterpene lactone endoperoxide isolated from Artemisia annua (sweet wormwood), is the cornerstone of first‑line artemisinin‑based combination therapies (ACTs) for malaria. Its concentration in plant material, extracts, and finished pharmaceutical products directly determines therapeutic efficacy, production yield, and economic viability. Accurate, reproducible, and stability‑indicating quantification of artemisinin is therefore essential for cultivar selection and breeding, harvest time optimisation, extraction process control, quality assurance of bulk drug substances, and compliance with international pharmacopoeial standards (e.g., WHO, USP, EP). Clients seeking artemisinin testing are typically engaged in plant cultivation and breeding, botanical extraction and purification, generic pharmaceutical manufacturing, or quality control laboratories. They require sensitive, specific, and validated analytical methods that can effectively separate artemisinin from its numerous co‑extracted components (including artemisinic acid, arteannuin B, and other sesquiterpenes) in complex plant matrices, and that can distinguish artemisinin from its degradation products (e.g., arteether, artemether, dihydroartemisinin) where applicable. Our laboratory provides a fully validated, multi‑method analytical platform that delivers high‑precision artemisinin quantification with isomer differentiation, comprehensive sample preparation support, and robust stability data, enabling you to ensure material consistency, maximise yield, and meet the most stringent regulatory requirements with the highest scientific credibility.

Why Professional Artemisinin Quantification Is Indispensable

The artemisinin content in Artemisia annua is highly variable, depending on genotype, geographic origin, harvest season, drying methods, and storage conditions. Moreover, artemisinin is thermally labile and susceptible to photodegradation, acid‑catalysed rearrangement, and oxidation, particularly during extraction and processing. Inaccurate or imprecise analysis can lead to over‑ or under‑estimation of active content, incorrect dosing in formulated products, batch‑to‑batch inconsistency, and failure to meet pharmacopoeial specifications. Clients often encounter practical challenges such as poor extraction efficiency from fibrous leaf tissue, co‑elution of artemisinin with structurally similar sesquiterpenes, instability during sample preparation, and the need for very low detection limits in stability studies. Our comprehensive testing suite addresses these issues by employing state‑of‑the‑art high‑performance liquid chromatography (HPLC) with photodiode array (DAD) and mass spectrometry (MS) detection, as well as gas chromatography (GC) with flame ionisation (FID) and MS, coupled with matrix‑optimised extraction and rigorous method validation, ensuring reliable, stability‑indicating data that supports breeding, processing, and quality assurance programmes.

Our Advanced Analytical Suite for Artemisinin Quantification

We employ a fully validated, multi‑technique approach to quantify artemisinin and provide a comprehensive phytochemical profile for Artemisia annua samples:

High‑Precision HPLC‑DAD‑MS/MS Quantification – Our primary quantitative method uses reversed‑phase high‑performance liquid chromatography (HPLC) with a C18 or C8 column and a gradient elution using acidified water (0.1% formic acid) and acetonitrile to achieve baseline separation of artemisinin from other sesquiterpenes (such as artemisinic acid, arteannuin B, and artemisinin A/B) within 30 minutes. We use a photodiode array detector (DAD) at 210 nm (the end‑absorption maximum of artemisinin) and, for definitive confirmation, a triple‑quadrupole or high‑resolution mass spectrometer (MS/MS) monitoring the characteristic precursor‑to‑product ion transitions (e.g., m/z 283 → 191 for artemisinin in negative mode). Our method is validated for linearity (R² > 0.999 over 0.1–500 µg/mL), precision (intra‑day RSD < 1.0%, inter‑day RSD < 2.0%), accuracy (recovery 97–103% from spiked matrix), and specificity. The limit of detection (LOD) is 0.05 µg/mL and the limit of quantification (LOQ) is 0.1 µg/mL in standard solutions, with matrix‑equivalent values determined for each sample type. We report both absolute concentration (µg/g dry weight or fresh weight) and relative purity (%) of artemisinin in the sample.

Complementary GC‑MS Analysis for Thermal Stability and Volatile Profiling – For samples requiring distinction from thermally stable derivatives or for cross‑validation, we offer gas chromatography‑mass spectrometry (GC‑MS) after derivatisation (e.g., silylation). This is particularly valuable for detection of artemisinin in the presence of degradation products or for quantitative confirmation when HPLC signals are compromised by matrix interferences. Our GC‑MS method achieves similar LOD/LOQ levels and provides an independent orthogonal confirmation of identity.

Optimised Extraction and Sample Preparation for Artemisia Annua Matrices – Plant materials contain waxes, chlorophyll, and polyphenols that can interfere with analysis. We have developed a validated extraction protocol using ultrasonic‑assisted extraction with 70% ethanol or methanol (with antioxidant stabilisation, e.g., BHT or ascorbic acid) at room temperature, followed by centrifugation, filtration, and optional solid‑phase extraction (SPE) cleanup using C18 or silica cartridges to remove interfering co‑extractives. Our protocols ensure extraction efficiency > 96% for artemisinin, verified using standard addition and certified reference materials (where available). We also offer pressurised liquid extraction (PLE) and microwave‑assisted extraction for high‑throughput processing.

Stability Studies and Degradation Monitoring – Artemisinin is susceptible to degradation under acidic, basic, oxidative, and photolytic conditions. We conduct ICH‑compliant forced degradation studies (thermal, photolytic, oxidative, and pH stress) and monitor the loss of artemisinin and the formation of known degradation products (e.g., arteether, artemether, dihydroartemisinin, and various decomposition products) by HPLC‑DAD‑MS/MS. We provide kinetic degradation parameters (half‑life, activation energy) and recommend optimal storage, handling, and processing conditions to maintain product integrity. These data are critical for setting shelf‑life specifications and for validating analytical procedures as stability‑indicating.

Identification and Quantification of Related Sesquiterpenes and Impurities – In addition to artemisinin, we can quantify other bioactive sesquiterpenes such as artemisinic acid, arteannuin B, and artemisinin B, which are important for chemotaxonomy and processing optimisation. We also screen for artemisinin dimer and other process‑related impurities using untargeted MS detection. This provides a complete phytochemical fingerprint of your Artemisia annua material.

Method Validation and Regulatory Compliance – All our artemisinin assays are performed under ISO/IEC 17025 accreditation and follow the principles of ICH Q2(R1) and WHO/Ph. Eur. guidelines. We provide a comprehensive certificate of analysis (CoA) that includes artemisinin concentration, measurement uncertainty, method details, and a clear pass/fail statement against client specifications. For clients requiring regulatory submissions, we offer full method validation packages and technical consultancy on impurity profiling and stability testing.

Our Distinctive Competencies and Unmatched Analytical Depth

Our service is uniquely distinguished by the integration of orthogonal HPLC‑MS and GC‑MS methods, matrix‑optimised extraction, and comprehensive stability studies—all performed on the same representative sample to provide a complete, cross‑validated quality profile. We maintain in‑house reference standards for artemisinin, artemisinic acid, and arteannuin B with documented purity, and we participate in international proficiency testing schemes (e.g., FAPAS, AOCS) to ensure global comparability. Our proprietary “Artemisinin Quality and Stability Index” (AQSI™) combines artemisinin content, impurity level, and degradation half‑life into a single numeric score that predicts processability and shelf‑life potential. This index has been validated across more than 50 commercial and experimental Artemisia annua cultivars.

We achieve exceptional measurement precision: < 0.5% RSD for artemisinin at mid‑range concentrations, < 1.0% for extraction reproducibility, and < 2.0% for inter‑assay variability. Our turnaround time for routine artemisinin quantification is 5–7 working days, with expedited 3‑day service available for time‑sensitive harvest assessments or batch release. Crucially, our team of PhD‑level phytochemists, analytical chemists, and pharmaceutical quality experts provides a comprehensive interpretative report that goes beyond numerical data—we help you understand the impact of cultivar selection, drying conditions, and extraction methods on artemisinin yield, and we recommend optimal harvesting windows and stabilisation strategies to maximise recovery. With over 40 successful projects on artemisinin and other plant secondary metabolites, we empower our clients to achieve consistent active content, reduce production costs, and meet international pharmacopoeial standards with the highest level of scientific rigour and practical expertise.

To discuss your artemisinin testing requirements or to request a customised analytical plan, please contact our technical team for a confidential consultation and a detailed quotation.